1. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis 
Peter Heering, MD, Norbert Braun, MD, Reinhard Müllejans, MD, Katrin Ivens, MD, Ingeborg Zäuner, MD, Reinhard Fünfstück, MD, Frieder Keller, MD, Bernhard K Krämer, MD, Peter Schollmeyer, MD, Teut Risler, MD, Bernd Grabensee, MD 
American Journal of Kidney Diseases 
Volume 43, Issue 1, Pages (January 2004)
DOI: /j.ajkd
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
Follow-up of patients included in the study on the basis of an intention to treat.
American Journal of Kidney Diseases  , 10-18DOI: ( /j.ajkd )
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

3. Fig 2
Creatinine in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. To convert creatinine in mg/dL to μmol/L, multiply by 88.4.
American Journal of Kidney Diseases  , 10-18DOI: ( /j.ajkd )
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

4. Fig 3
Renal survival in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study.
American Journal of Kidney Diseases  , 10-18DOI: ( /j.ajkd )
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

5. Fig 4
Cholesterol in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. To convert cholesterol in mg/dL to mmol/L, multiply by
American Journal of Kidney Diseases  , 10-18DOI: ( /j.ajkd )
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

6. Fig 5
Proteinuria in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study.
American Journal of Kidney Diseases  , 10-18DOI: ( /j.ajkd )
Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions